Surgical outcome of cataract secondary to human T-lymphotoropic virus type 1 uveitis Tatsushi Kawaguchi 1 , Tetsuya Takahashi 1 , Tetsuro Tanabe 1 , Tomokazu Samejima 1 , Kazunori Miyata 1 , Manabu Mochizuki 2 1Miyata Eye Hosp 2Dept of Ophthalmol & Visual Science, Tokyo Med and Dental Univ Graduate Sch pp.267-270
Published Date 2002/3/15
DOI https://doi.org/10.11477/mf.1410907626
  • Abstract
  • Look Inside

We reviewed the outcome of surgery for cataract secondary to human T-lymphotropic virus type 1 (HTLV-1) uveitis. The series comprised 34 eyes of 24 patients with HTLV-1 uveitis, including 4 males and 20 fe-males. Their age ranged from 32 to 82 years, average 59 years. All the eyes had been free of inflammation during 2 months before surgery. Phacoemulsification and aspiration (PEA) was performed on 27 eyes, and extracapsular cata-ract extraction (ECCE) on 7 eyes. Intraocular lens was implanted in 25 eyes. The visual acuity improved in all the eyes after surgery, averaging 0.72±0.48. Uveitis recurred in 19 eyes (56%) after an average of 13.1±7.3 months postop-eratively. There was no correlation between recurrence of uveitis and postoperative visual acuity. The findings show that surgery is indicated for cataract secondary to HTLV-1 uveitis after ocular inflammation has subsided.

Copyright © 2002, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院